FDA approves 10 cities across USA to administer MDMA in a Phase 3 clinical trial.
Imperial College of London Centre for Psychedelic Research is studying the effects on Psilocybin and treating Fibromyalgia.
A theory that low doses of psychedelics induce their effects via alterations in the gut microbiome and related pathways to the brain.
Lifetime use of naturalistic psychedelics was associated with a 60% reduced hazard for suicidality.
Psychedelic use resulted in a 14% reduced likelihood of suicidal thinking within the past year, a 29% reduced likelihood of suicide planning
within the past year, and a 36% reduced likelihood of attempting suicide within the past year.
97 clinical trials recruiting volunteer participants.
You must be 21 years old to access this website and the information contained within it. Please STOP reading and exit the site if you are under 21 years of age. By reading further, you warrant that you are 21 or older. Additionally, we do not provide or sell any drugs or plants. Attempts to sell or source drugs or plants are strictly unwelcome. F.E.M and its organizers do not condone or encourage any illegal activities, including but not limited to the use of illegal substances. This site is not a substitute for medical, psychological, or psychiatric diagnosis, treatment, or advice.